Jeanne Maugein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jeanne Maugein has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
J Fourche
4 shared publicationsJ L Pellegrin
3 shared publicationsM Mormede
2 shared publications- Alain Charron
Laboratoire de Bactériologie EA 3671, Université Victor Segalen Bordeaux 2, CHU de Bordeaux, 33076 Bordeaux Cedex, France
1 shared publication - Armelle Ménard
University of Bordeaux Department of Biologic and Medical Sciences: Universite de Bordeaux Departement Sciences Biologiques et Medicales
1 shared publication B. Carbonnelle
1 shared publication
Latest Publications
- Open Access
- 18 March 2010
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 10 (1) , 72
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study
Meropenem is a carbapenem that has an excellent activity against many gram-positive and gram-negative aerobic, facultative, and anaerobic bacteria. The major objective of the present study was to assess the in vitro activity of meropenem compared to imipenem and piperacillin/tazobactam, against 1071 non-repetitive isolates collected from patients with bacteremia (55%), pneumonia (29%), peritonitis (12%) and wound infections (3%), in 15 French hospitals in 2006. The secondary aim of the study was to compare the results of routinely testings and those obtained by a referent laboratory.
- 18 March 2010
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 10 (1) , 72
Open AccessComparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study
Meropenem is a carbapenem that has an excellent activity against many gram-positive and gram-negative aerobic, facultative, and anaerobic bacteria. The major objective of the present study was to assess the in vitro activity of meropenem compared to imipenem and piperacillin/tazobactam, against 1071 non-repetitive isolates collected from patients with bacteremia (55%), pneumonia (29%), peritonitis (12%) and wound infections (3%), in 15 French hospitals in 2006. The secondary aim of the study was to compare the results of routinely testings and those obtained by a referent laboratory.
- Open Access
- 1 January 2010
- Published by Springer Nature in BMC Microbiology
- Vol. 10 (1) , 93
Variable-number tandem-repeat markers for typing Mycobacterium intracellulare strains isolated in humans
Mycobacterium intracellulare, a species of the Mycobacterium avium complex, may be the cause of severe lung, lymphatic node, skin and bone/joint infections, as well as bacteriemia. The goal of this work was to identify Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeat (MIRU-VNTR) markers and to study their variability in a collection of isolates of M. intracellulare collected in humans. We studied 61 isolates collected in humans between 2001 and 2008, as well as the reference strain, M. intracellulare ATCC 13950.
- 1 January 2010
- Published by Springer Nature in BMC Microbiology
- Vol. 10 (1) , 93
Open AccessVariable-number tandem-repeat markers for typing Mycobacterium intracellulare strains isolated in humans
Mycobacterium intracellulare, a species of the Mycobacterium avium complex, may be the cause of severe lung, lymphatic node, skin and bone/joint infections, as well as bacteriemia. The goal of this work was to identify Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeat (MIRU-VNTR) markers and to study their variability in a collection of isolates of M. intracellulare collected in humans. We studied 61 isolates collected in humans between 2001 and 2008, as well as the reference strain, M. intracellulare ATCC 13950.
- Open Access
- 12 November 2009
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 8 (1) , 30
Tsukamurella tyrosinosolvens - An unusual case report of bacteremic pneumonia after lung transplantation
Background: Lung transplant recipients have an increased risk for actinomycetales infection secondary to immunosuppressive regimen. Case presentation: A case of pulmonary infection with bacteremia due to Tsukamurella tyrosinosolvens in a 54-year old man who underwent a double lung transplantation four years previously is presented. Conclusion: The identification by conventional biochemical assays was unsuccessful and hsp gene sequencing was used to identify Tsukamurella tyrosinosolvens.
- 12 November 2009
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 8 (1) , 30
Open AccessTsukamurella tyrosinosolvens - An unusual case report of bacteremic pneumonia after lung transplantation
Background: Lung transplant recipients have an increased risk for actinomycetales infection secondary to immunosuppressive regimen. Case presentation: A case of pulmonary infection with bacteremia due to Tsukamurella tyrosinosolvens in a 54-year old man who underwent a double lung transplantation four years previously is presented. Conclusion: The identification by conventional biochemical assays was unsuccessful and hsp gene sequencing was used to identify Tsukamurella tyrosinosolvens.
- 30 June 2008
- Published by Elsevier in Option/Bio
- Vol. 19 (402) , 20-21
De nombreux réactifs de coloration à l’auramine à notre disposition
- 30 June 2008
- Published by Elsevier in Option/Bio
- Vol. 19 (402) , 20-21
De nombreux réactifs de coloration à l’auramine à notre disposition
- 1 May 2008
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 25 (6) , 37-39
Techniques d’identification microbiologiques et antibiogrammes
- 1 May 2008
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 25 (6) , 37-39
Techniques d’identification microbiologiques et antibiogrammes
- 1 December 2005
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 26 (6) , 1092-1096
Sentinel-site surveillance ofMycobacterium aviumcomplex pulmonary disease
The incidence ofMycobacterium aviumcomplex (MAC) pulmonary disease in HIV-negative patients was studied prospectively from January 1, 2000 to December 31, 2002 through 32 sentinel sites distributed all over France.Among the 275 patients who yielded MAC isolates from respiratory clinical specimens, 101 (36.7%) met the bacteriological, radiographical and clinical criteria established by the American Thoracic Society for nontuberculous mycobacterial respiratory disease. Of these 101 patients, 81 had underlying lung disease, mainly previous tuberculosis, bronchectasis or chronic obstructive pulmonary disease.Among the 20 patients with no underlying lung disease, 12 had a predisposing factor such as leukaemia or immunosuppressive treatment and eight had no predisposing factor. All patients with MAC respiratory disease had clinical symptoms, commonly cough and fatigue, and 52 (51.5%) were sputum smear positive for acid-fast bacillus.The ratio of patients withMycobacterium aviumcomplex pulmonary disease to patients with pulmonary tuberculosis in France was estimated to be 3% and the incidence ofMycobacterium aviumcomplex pulmonary disease in France was 0.2 per 100,000 inhabitants.
- 1 December 2005
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 26 (6) , 1092-1096
Sentinel-site surveillance ofMycobacterium aviumcomplex pulmonary disease
The incidence ofMycobacterium aviumcomplex (MAC) pulmonary disease in HIV-negative patients was studied prospectively from January 1, 2000 to December 31, 2002 through 32 sentinel sites distributed all over France.Among the 275 patients who yielded MAC isolates from respiratory clinical specimens, 101 (36.7%) met the bacteriological, radiographical and clinical criteria established by the American Thoracic Society for nontuberculous mycobacterial respiratory disease. Of these 101 patients, 81 had underlying lung disease, mainly previous tuberculosis, bronchectasis or chronic obstructive pulmonary disease.Among the 20 patients with no underlying lung disease, 12 had a predisposing factor such as leukaemia or immunosuppressive treatment and eight had no predisposing factor. All patients with MAC respiratory disease had clinical symptoms, commonly cough and fatigue, and 52 (51.5%) were sputum smear positive for acid-fast bacillus.The ratio of patients withMycobacterium aviumcomplex pulmonary disease to patients with pulmonary tuberculosis in France was estimated to be 3% and the incidence ofMycobacterium aviumcomplex pulmonary disease in France was 0.2 per 100,000 inhabitants.
- 1 April 2003
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 9 (4) , 280-288
Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties
- 1 April 2003
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 9 (4) , 280-288
Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties
- 31 October 2002
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 44 (2) , 151-155
Evaluation of the BDProbeTec™ ET DTB assay for direct detection of Mycobacterium tuberculosis complex from clinical samples
- 31 October 2002
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 44 (2) , 151-155
Evaluation of the BDProbeTec™ ET DTB assay for direct detection of Mycobacterium tuberculosis complex from clinical samples
- 1 January 2001
- Published by Elsevier in Pathologie Biologie
- Vol. 49 (7) , 583-586
Activité in vitro de la pristinamycine sur Streptococcus pneumoniae
- 1 January 2001
- Published by Elsevier in Pathologie Biologie
- Vol. 49 (7) , 583-586
Activité in vitro de la pristinamycine sur Streptococcus pneumoniae
- 1 May 1996
- Vol. 44 (5) , 435-41
[Molecular typing by pulsed field gel electrophoresis of Stenotrophomonas maltophilia isolated in a department of hematology].
Stenotrophomonas maltophilia is an important nosocomial pathogen. The increased isolates of S. maltophilia among hematology unit patients led to an epidemiological survey. Over 26 months, 24 strains isolated from 23 patients and an environmental isolate from blood pressure armband have been identified. The isolated were first analysed by the use of phenotypical markers: biotype, antibiotic susceptibility, but the minor differences observed justified a genotypic analysis. Pulsed field gel electrophoresis of genomic DNA was carried with XbaI and DraI restriction endonucleases by contour-clamped homogeneous electric field method (CHEF). The data obtained showed a great genomic diversity within the species S. maltophilia. Nevertheless, the same restriction profile was found for 3 patients and 3 other profiles were obtained for 3 couples of patients hospitalized at the same time. All the other strains isolated from subjects hospitalized during the same period exhibited pulsotypes independent from each other. Compared to biotypes and antibiotic susceptibility, these results indicate field only with non modified primers, and the absence of 460 mutations was confirmed by sequencing. Two isolates P1 and P2, from a transplanted patient were amplified with both primers MCMM and MCMW: sequencing analysis shown the presence of a mixture of strains, one of them harbouring A- > G 1378 mutation. One resistant strain was amplified neither with MCMM nor with MCMW: a C- > T silent mutation at nt 1368 was present. As sequencing analysis confirmed PCR results, discriminative PCR enables isolates to be rapidly assessed for the presence or absence of 460 mutations. Moreover, it can distinguish Met to Val from Met to Ile mutations, and allows the analysis of mixtures of sensitive and resistant strains.
- 1 May 1996
- Vol. 44 (5) , 435-41
[Molecular typing by pulsed field gel electrophoresis of Stenotrophomonas maltophilia isolated in a department of hematology].
Stenotrophomonas maltophilia is an important nosocomial pathogen. The increased isolates of S. maltophilia among hematology unit patients led to an epidemiological survey. Over 26 months, 24 strains isolated from 23 patients and an environmental isolate from blood pressure armband have been identified. The isolated were first analysed by the use of phenotypical markers: biotype, antibiotic susceptibility, but the minor differences observed justified a genotypic analysis. Pulsed field gel electrophoresis of genomic DNA was carried with XbaI and DraI restriction endonucleases by contour-clamped homogeneous electric field method (CHEF). The data obtained showed a great genomic diversity within the species S. maltophilia. Nevertheless, the same restriction profile was found for 3 patients and 3 other profiles were obtained for 3 couples of patients hospitalized at the same time. All the other strains isolated from subjects hospitalized during the same period exhibited pulsotypes independent from each other. Compared to biotypes and antibiotic susceptibility, these results indicate field only with non modified primers, and the absence of 460 mutations was confirmed by sequencing. Two isolates P1 and P2, from a transplanted patient were amplified with both primers MCMM and MCMW: sequencing analysis shown the presence of a mixture of strains, one of them harbouring A- > G 1378 mutation. One resistant strain was amplified neither with MCMM nor with MCMW: a C- > T silent mutation at nt 1368 was present. As sequencing analysis confirmed PCR results, discriminative PCR enables isolates to be rapidly assessed for the presence or absence of 460 mutations. Moreover, it can distinguish Met to Val from Met to Ile mutations, and allows the analysis of mixtures of sensitive and resistant strains.